oxybutynin has been researched along with tretinoin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hiraishi, Y; Hirobe, S; Kamiyama, F; Nakagawa, S; Nakagawa, T; Okada, N; Quan, YS | 1 |
| Asada, H; Hiraishi, Y; Hirobe, S; Iioka, H; Kamiyama, F; Nakagawa, S; Okada, N; Quan, YS | 1 |
| Asada, H; Hirobe, S; Iioka, H; Kamiyama, F; Nakagawa, S; Okada, N; Otsuka, R; Quan, YS | 1 |
1 review(s) available for oxybutynin and tretinoin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for oxybutynin and tretinoin
| Article | Year |
|---|---|
Development of a novel therapeutic approach using a retinoic acid-loaded microneedle patch for seborrheic keratosis treatment and safety study in humans.
Topics: Adult; Animals; Collagen; Cytokines; Dermatologic Agents; Drug Delivery Systems; Female; Heparin-binding EGF-like Growth Factor; Humans; Hyperplasia; Intercellular Signaling Peptides and Proteins; Keratosis, Seborrheic; Male; Mice; Mice, Hairless; Microinjections; Middle Aged; Needles; Receptors, Retinoic Acid; RNA, Messenger; Skin; Skin Irritancy Tests; Transdermal Patch; Tretinoin | 2013 |
4 other study(ies) available for oxybutynin and tretinoin
| Article | Year |
|---|---|
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Performance and characteristics evaluation of a sodium hyaluronate-based microneedle patch for a transcutaneous drug delivery system.
Topics: Administration, Cutaneous; Animals; Diphtheria Toxoid; Drug Combinations; Drug Delivery Systems; Drug Stability; Drug Storage; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humidity; Hyaluronic Acid; Mice; Mice, Hairless; Mice, Inbred ICR; Microinjections; Needles; Ovalbumin; Rats; Rats, Wistar; Tetanus Toxoid; Time Factors; Transdermal Patch; Tretinoin | 2013 |
Clinical study of a retinoic acid-loaded microneedle patch for seborrheic keratosis or senile lentigo.
Topics: Aged; Aged, 80 and over; Female; Humans; Keratolytic Agents; Keratosis, Seborrheic; Lentigo; Male; Middle Aged; Needles; Skin; Transdermal Patch; Tretinoin | 2017 |